Co-prescribing naloxone in Medicare Part D increases
Co-prescribing naloxone in Medicare Part D increases
Image by NIDA
The practice of co-prescribing the opioid overdose reversal drug naloxone to Medicare Part D patients who take opioids for chronic pain increased between 2016 and 2017, though such co-prescriptions were provided to only a small minority of patients who might benefit, according…
Go to Source
Powered by WPeMatico